NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
October 02 2015 - 5:00AM
What:
NovoCure Limited (Nasdaq:NVCR), a commercial stage oncology
company pioneering a novel therapy for solid tumors called Tumor
Treating Fields, will visit the Nasdaq MarketSite in Times Square
to celebrate its initial public offering (IPO).
In honor of the occasion, Asaf Danziger, Chief Executive
Officer and Bill Doyle, Executive Chairman will ring the
Opening Bell.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway –
Broadcast Studio
When:
Friday, October 2, 2015 – 9:15 a.m. to 9:30 a.m.
ET
NovoCure Limited Media Contact:Amy
Phillips(412) 327-9499aphil7@aol.com
Nasdaq MarketSite:William Briganti(646)
441-5012William.Briganti@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies please visit our Facebook page at:
http://www.facebook.com/NASDAQ.
For photos from ceremonies and events visit our Instagram
Page:
http://instagram.com/nasdaq
For news tweets, please visit our Twitter page at:
http://twitter.com/nasdaq
For exciting viral content and ceremony photos visit Tumblr
Page:
http://nasdaq.tumblr.com/
Webcast: A webcast of the Nasdaq Opening Bell
will be available at: https://new.livestream.com/nasdaq/live or
http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Open, please go to
http://www.nasdaq.com/reference/marketsite_events.stm and click on
the market open of your choice.
About NovoCure Limited
(Nasdaq:NVCR):
NovoCure Limited is a commercial-stage oncology company
pioneering a novel therapy for solid tumors called TTFields.
TFields is a low toxicity anti-mitotic treatment that uses
low-intensity, intermediate frequency, alternating electric fields
to exert physical forces on key molecules inside cancer cells,
disrupting the basic machinery necessary for normal cell division,
leading to cancer cell death. Headquartered in the Bailiwick of
Jersey, Novocure’s US operations are based in Portsmouth, NH and
New York, NY. Additionally, the company has offices in Germany,
Switzerland, and Japan and a research center in Haifa, Israel. For
additional information about the company, please visit
www.novocure.com or follow us at www.twitter.com/novocure.
About Nasdaq:
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing,
exchange technology, listing, information and public company
services across six continents. Through its diverse portfolio of
solutions, Nasdaq enables customers to plan, optimize and execute
their business vision with confidence, using proven technologies
that provide transparency and insight for navigating today's global
capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 70
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to more than 3,600 listed companies
with a market value of approximately $9.6 trillion and more than
10,000 corporate clients. To learn more, visit: nasdaq.com/ambition
or business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2024 to May 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2023 to May 2024